Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis
Status:
Active, not recruiting
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether adult DKA patients who present to the
emergency department treated with early subcutaneous long acting insulin versus standard care
receive a shorter total duration of intravenous (IV) insulin infusion.
Phase:
N/A
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore